D-Tagatose One of Top 10 Most Promising CV/Metabolic Drugs in Development

D-Tagatose One of Top 10 Most Promising CV/Metabolic Drugs in Development: D-Tagatose, first in class, to treat diabetes could be the next new drug approved for diabetes and for the treatment of hypertriglyceridemia levels, pending results of the NEET trial. The effect on triglycerides is a secondary endpoint of the current Phase 2 and Phase 3 trials for diabetes. D-tagatose, a naturally occurring sugar, is a low-calorie, full-bulk sweetener previously approved by the “FDA” as a GRAS (Generally Recognized As Safe) food ingredient. It is a true sugar that looks, feels, and tastes like table sugar. The company holds the patents for use of D-tagatose as a treatment for Type 2 diabetes.